Chemoinformaics analysis of 23-Keto-Spirostanol
| Molecular Weight | 430.629 | nRot | 1 |
| Heavy Atom Molecular Weight | 388.293 | nRig | 31 |
| Exact Molecular Weight | 430.308 | nRing | 6 |
| Solubility: LogS | -5.778 | nHRing | 2 |
| Solubility: LogP | 5.238 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 76.3033 |
| nHD | 1 | BPOL | 46.4747 |
| QED | 0.638 |
| Synth | 5.438 |
| Natural Product Likeliness | 2.577 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.934 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.9 |
| MDCK | 0.0000403 |
| BBB | 0.962 |
| PPB | 0.969616 |
| VDSS | 1.226 |
| FU | 0.0184919 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.536 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.145 |
| CYP2c9-sub | 0.056 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.735 |
| CYP3a4-inh | 0.14 |
| CYP3a4-sub | 0.691 |
| CL | 21.622 |
| T12 | 0.054 |
| hERG | 0.023 |
| Ames | 0.065 |
| ROA | 0.855 |
| SkinSen | 0.667 |
| Carcinogencity | 0.055 |
| EI | 0.01 |
| Respiratory | 0.775 |
| NR-Aromatase | 0.773 |
| Antiviral | Yes |
| Prediction | 0.764116 |